Clinical characteristics
. | ASCT patients (n = 12) . | Conventionally treated patients (n = 8) . |
|---|---|---|
| Male patients, no. | 6 | 5 |
| Onset type JIA, no. | ||
| Systemic | 9 | 8 |
| Polyarticular | 3 | 0 |
| Age at onset JIA, y/mo (range) | 3/10 (0/11-7/7) | 5/9 (1/10-16/1) |
| Age at ASCT, y/mo (range) | 9/10 (5/2-14/11) | NA |
| Follow-up, y/mo (range) | 4/6 (0/4-7/0) | NA |
| Outcome at maximal follow-up, no. | ||
| Complete remission | 6 | NA |
| 50%-70% response | 3 | NA |
| Complete relapse | 2 | NA |
| Deceased | 1 | NA |
. | ASCT patients (n = 12) . | Conventionally treated patients (n = 8) . |
|---|---|---|
| Male patients, no. | 6 | 5 |
| Onset type JIA, no. | ||
| Systemic | 9 | 8 |
| Polyarticular | 3 | 0 |
| Age at onset JIA, y/mo (range) | 3/10 (0/11-7/7) | 5/9 (1/10-16/1) |
| Age at ASCT, y/mo (range) | 9/10 (5/2-14/11) | NA |
| Follow-up, y/mo (range) | 4/6 (0/4-7/0) | NA |
| Outcome at maximal follow-up, no. | ||
| Complete remission | 6 | NA |
| 50%-70% response | 3 | NA |
| Complete relapse | 2 | NA |
| Deceased | 1 | NA |
Clinical characteristics of ASCT and conventionally treated patients. Patients who are in complete remission are drug-free and fulfill at least 5 or more of the following requirements for the last 2 consecutive months: morning stiffness less than 30 minutes, no fatigue, no joint pain, no joint tenderness or pain on motion, no soft tissue swelling in joints or tendon sheaths, and erythrocyte sedimentation rate less than 20 mm/h.
NA indicates not applicable.